Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria
{{output}}
Erythropoietic protoporphyria (EPP) is a rare disease in which patients experience severe light sensitivity. It is caused by a deficiency of ferrochelatase (FECH), the last enzyme in heme biosynthesis (HBS). The lack of FECH causes accumulation of its photorea... ...
